Lou Yu Yan

Director/Board Member at ESLITE SPECTRUM CORPORATION

Finance

Communications

Electronic Technology

Profile

Lou Yu Yan currently works at Qisda Corp., as Independent Director from 2020, Sinyi Realty, Inc., as Independent Director from 2017, ANZ Banking Corp., as Independent Director, and The Eslite Spectrum Corp., as Independent Director.
Mr. Yan also formerly worked at Chunghwa Telecom Co., Ltd., as Independent Director and Crown Bioscience International, as Independent Director.
Mr. Yan received his graduate degree from National Chengchi University.

Lou Yu Yan active positions

Companies	Position	Start
ESLITE SPECTRUM CORPORATION	Director/Board Member	-
SINYI REALTY INC.	Director/Board Member	2017-05-25
QISDA CORPORATION	Director/Board Member	2020-06-18
ANZ Banking Corp. ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia.	Director/Board Member	-

All active positions of Lou Yu Yan

Former positions of Lou Yu Yan

Companies	Position	End
CHUNGHWA TELECOM CO., LTD.	Director/Board Member	-
CROWN BIOSCIENCE INTERNATIONAL	Director/Board Member	-

See the detail of Lou Yu Yan's experience

Training of Lou Yu Yan

National Chengchi University

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lou Yu Yan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	4
CHUNGHWA TELECOM CO., LTD.	Communications
QISDA CORPORATION	Electronic Technology
SINYI REALTY INC.	Finance
ESLITE SPECTRUM CORPORATION	Finance

Private companies	2
ANZ Banking Corp. ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia.	Finance
Crown Bioscience International Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan.	Health Technology